Peptides as immune suppressant Technology APIM-peptides are synthetic cell-penetrating peptides that target DNA sliding clamps in both bacteria and mammalian cells. In stressed ma [...]
UniqueAlgea
arved anhalt2025-09-30T07:02:34+00:00Unique algea producing non-toxic active metabolite with health beneficial properties Technology The research team at NTNU has developed a mutant alga which produces a potent antiox [...]
TheraLeuk
arved anhalt2025-09-30T08:23:32+00:00More precise treatment against leukemia Technology A novel RNA-targeting medicine against leukemia that is more precise than today's options, resulting in less side effects. This [...]
Micro Glucagon
arved anhalt2025-04-01T06:00:17+00:00A novel method to improve treatment of type 1 diabetes Technology Micro doses of glucagon, where glucagon itself exerts minimal effect on glucose levels, results in faster SC insul [...]
Betatide
arved anhalt2025-10-01T07:22:40+00:00Drug for reducing antibiotic resistance and killing bacteria Technology Betatide is a novel synthetic cell-penetrating peptide that attacks bacteria in a fundamentally new way. It [...]
Lybe Scientific
arved anhalt2022-08-22T09:45:03+00:00Fast and sensitive nanoparticle-based extraction for life science and diagnostics Business idea Development of universal cost-effective sample preparation solutions covering a wid [...]
Nordic Brain Tech
arved anhalt2022-08-22T10:31:46+00:00Predicting brain disorders with biofeedback Business idea We develop easy-to-use and scientifically proven technology to help people predict and prevent brain disorders. Market Br [...]
Glucoset
arved anhalt2022-08-22T10:20:35+00:00Accurate Continuous Glucose Control Business idea GlucoSet develops tools for accurate continuous glucose monitoring in Intensive Care Units, to reduce patient mortality and hospi [...]
In-Motion
arved anhalt2022-08-24T11:13:08+00:00Lowering age of Cerebral Palsy detection and intervention Technology Unique AI-based medical tool for early prediction of Cerebral Palsy in infants allowing targeted intervention [...]
Revie
arved anhalt2024-08-01T12:13:42+00:00Novel CSF1R-inibitor drugs TechnologyOur researchers at NTNU have synthesized novel small molecule inhibitors with great selectively towards the tyrosine kinase receptor, CSF1R. CS [...]









